Establishment Labs Overview
- Founded
-
2004
- Status
-
Public
- Employees
-
887
- Stock Symbol
-
ESTA
- Investments
-
3
- Share Price
-
$67.22
- (As of Monday Closing)
Establishment Labs General Information
Description
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in designing, manufacturing, and marketing silicone-filled breast and body shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
Contact Information
Website
www.establishmentlabs.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Stock Exchange
NAS
Primary Office
- Coyol Free Zone
- Alajuela
- Costa Rica
Establishment Labs Stock Performance
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $67.22 | $66.02 | $44.02 - $93.80 | $1.64B | 24.3M | 161K | -$3.12 |
Establishment Labs Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|---|
| EV | 1,381,648 | 1,611,530 | 850,208 | 575,378 |
| Revenue | 153,200 | 126,682 | 84,676 | 89,565 |
| EBITDA | (57,449) | (26,549) | (24,948) | (25,530) |
| Net Income | (75,838) | (41,139) | (38,121) | (38,150) |
| Total Assets | 187,653 | 139,529 | 156,388 | 116,531 |
| Total Debt | 152,074 | 54,208 | 52,543 | 48,400 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Establishment Labs Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Establishment Labs Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic produc
Therapeutic Devices
Alajuela, Costa Rica
887
As of 2022
00000
00000000
00000
000000
ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit
00000000 0000000
Princeton, NJ
0000
As of 0000
00000
000000 - 000
00000
000000
quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequ
00000 0000000 000 00
Irvine, CA
000
As of 0000
0000
0000
0000-00-00
00000000
0000
Add Comparison
Establishment Labs Competitors (9)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Integra Lifesciences Holdings | Corporation | Princeton, NJ | 0000 | 00000 | 000000 - 000 | 00000 |
| 000000 | Formerly VC-backed | Irvine, CA | 000 | 0000 | 00000000 | 0000 |
| 00000 0000000 | Formerly VC-backed | Toronto, Canada | 000 | 00000 | 000000000 | 00000 |
| 0000000 | Formerly VC-backed | Santa Barbara, CA | 000 | 00000 | 000000 - 000 | 00000 |
| 000000000 | Corporation | Minneapolis, MN | 00000 | 00000000 |
Establishment Labs Patents
Establishment Labs Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220338808-A1 | Methods and systems for sensing parameters in implantable devices | Pending | 02-Oct-2019 | 00000000 | |
| CA-3156319-A1 | Methods and systems for sensing parameters in implantable devices | Pending | 02-Oct-2019 | 000000000 | |
| EP-4041059-A1 | Methods and systems for sensing parameters in implantable devices | Pending | 02-Oct-2019 | 000000000 | |
| EP-3860479-A1 | Insertion devices and methods of use thereof | Pending | 03-Oct-2018 | 000000000 | |
| US-20200111213-A1 | Systems and methods of monitoring medical implants | Pending | 03-Oct-2018 | G06T7/0014 | 0 |
Establishment Labs Executive Team (11)
Establishment Labs Board Members (11)
| Name | Representing | Role | Since |
|---|---|---|---|
| Dennis Condon | Establishment Labs | Board Member | 000 0000 |
| Edward Schutter | Establishment Labs | Board Member | 000 0000 |
| Juan Chacón-Quirós | Establishment Labs | Founder, Chief Executive Officer & Board Member | 000 0000 |
| Leslie Gillin | Self | Board Member | 000 0000 |
| Lisa Colleran | Establishment Labs | Board Member | 000 0000 |
Establishment Labs Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Establishment Labs Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Establishment Labs Investments & Acquisitions (3)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000 0000000 ( | 31-Jan-2019 | 000000000 | 00.000 | Buildings and Property | |
| 00000000 (000 | 17-Nov-2017 | 0000000000 | 00.000 | Distributors/Wholesale | |
| Magna Equities I (Certain Assets) | 01-Nov-2015 | Corporate Asset Purchase | Buildings and Property |
Establishment Labs ESG
Risk Overview
Risk Rating
Updated April, 01, 2022
38.51 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
00.00
Management
Management is related to actions taken to manage ESG issues
00.00
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
00 of 15,613
Rank
00.00
Percentile
Healthcare
Industry
00 of 635
Rank
00.00
Percentile
Medical Devices
Subindustry
00 of 228
Rank
00.00
Percentile
